Status:
COMPLETED
Balance and Motion Coordination Parameters Can be Improved in Patients With Type 2 Diabetes
Lead Sponsor:
Medical University of Warsaw
Conditions:
Diabetes Mellitus, Type 2
Gait Disorders, Neurologic
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Diabetes mellitus type II (DMII) causes many complications, including retinopathy and peripheral neuropathy. These complications are well understood and believed to contribute to gait instability and ...
Detailed Description
It is estimated that by the end of 2017 year, there will be 462 millions of patients suffering from diabetes mellitus type II (DMII), what is about 6% of world population (4,4% between 15 and 49 years...
Eligibility Criteria
Inclusion
- willingness to participate in the study
- age over 65
- diagnosed type 2 diabetes, subjected to pharmacological treatment (study group)
- no type 2 diabetes (control group)
Exclusion
- unwillingness to participate in the study
- age below 65 years
- surgical intervention in the lower limbs or spine during the last 6 months
- symptoms of osteoarthritis or pain of another origin around the lower limbs or spine
- rheumatic diseases (eg. rheumatoid arthritis, ankylosing spondylitis)
- diagnosed neuromuscular disease
- strongly manifested imbalances due to impairment of central or peripheral nervous system
- neurological disorders with dizziness, nystagmus, dermatologic or profound (cerebrospinal syndrome, dizziness, multiple sclerosis, Parkinson's disease, etc.).
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2020
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT04484480
Start Date
January 1 2020
End Date
April 1 2020
Last Update
July 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Othopedics and Rehabilitation, Medical University of Warsaw
Warsaw, Masovian Voivodeship, Poland, 03-984